Head-to-Head test aims to find best drug for millions with sinus polyps
NCT ID NCT06824649
Summary
This study aims to find out which of three newer biologic drugs works best for adults with chronic sinusitis and nasal polyps. Researchers will compare dupilumab, omalizumab, and mepolizumab in 504 participants to see which one most improves sinus symptoms and quality of life. The goal is to help doctors choose the right drug for each patient.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SINUSITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.